KaloBios Pharmaceuticals Inc (NASDAQ:KBIO)

0.755
Delayed Data
As of Mar 04
 +0.055 / +7.86%
Today’s Change
0.36
Today|||52-Week Range
3.69
-56.36%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for KaloBios Pharmaceuticals Inc have a median target of 8.00, with a high estimate of 8.00 and a low estimate of 8.00. The median estimate represents a +959.60% increase from the last price of 0.76.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in KaloBios Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.30
Sales
$0.00
Reporting Date
Mar 12

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -25.00%
 
 
 
 
 
 
Growthannually 32.95%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
 
Growthannually --
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account